Analyst Ratings For NYSE:EW – Edwards Lifesciences (NYSE:EW)
Today, Royal Bank of Canada raised its price target on NYSE:EW – Edwards Lifesciences (NYSE:EW) to per share.
Some recent analyst ratings include
- 4/25/2018-Northland Securities was Downgraded by analysts at Northland Securities from a “Outperform ➝ Market Perform” rating to a “” rating.
- 4/10/2018-SunTrust Banks Reiterated Rating of Buy.
- 3/20/2018-Cowen Reiterated Rating of Buy.
- 2/2/2018-Guggenheim Reiterated Rating of Buy.
- 2/2/2018-Stifel Nicolaus Reiterated Rating of Buy.
Recent Insider Trading Activity For NYSE:EW – Edwards Lifesciences (NYSE:EW)
NYSE:EW – Edwards Lifesciences (NYSE:EW) has insider ownership of 1.84% and institutional ownership of 81.03%.
- On 5/17/2018 Michael A Mussallem, CEO, sold 32,900 with an average share price of $135.88 per share and the total transaction amounting to $4,470,452.00.
- On 5/15/2018 Larry L. Wood, VP, sold 6,300 with an average share price of $137.26 per share and the total transaction amounting to $864,738.00.
- On 5/9/2018 Jean-Luc M Lemercier, VP, sold 5,634 with an average share price of $134.91 per share and the total transaction amounting to $760,082.94.
- On 5/9/2018 Scott B Ullem, CFO, sold 25,000 with an average share price of $134.73 per share and the total transaction amounting to $3,368,250.00.
- On 5/7/2018 Michael A Mussallem, CEO, sold 32,800 with an average share price of $136.37 per share and the total transaction amounting to $4,472,936.00.
- On 5/4/2018 Huimin Wang, VP, sold 3,800 with an average share price of $131.93 per share and the total transaction amounting to $501,334.00.
- On 4/30/2018 Michael A Mussallem, CEO, sold 32,800 with an average share price of $128.46 per share and the total transaction amounting to $4,213,488.00.
Recent Trading Activity for NYSE:EW – Edwards Lifesciences (NYSE:EW)
Shares of NYSE:EW – Edwards Lifesciences closed the previous trading session at 138.84 up +2.15 1.57% with 136.27999877929688 shares trading hands.